| Literature DB >> 23082228 |
Christian G Ramos1, Paulo J P da Costa, Gerd Döring, Jorge H Leitão.
Abstract
Small non-coding regulatory RNAs (sRNAs) post-transcriptionally affect multiple phenotypes in prokaryotes and eukaryotes, yet most of the underlying regulatory mechanisms and the nature of the target mRNAs remain unclear. Here we report the identification and functional analysis of the novel cis-encoded sRNA h2cR, from the human opportunistic pathogen Burkholderia cenocepacia J2315. The sRNA was found to negatively regulate the hfq2 mRNA, through binding to part of the 5'-UTR region of the hfq2 mRNA, resulting in accelerated hfq2 mRNA decay and reduced protein levels in exponentially growing cells. Both the h2cR transcript and the hfq2 mRNA are stabilized by the other B. cenocepacia RNA chaperone, Hfq. Infection experiments using the nematode Caenorhabditis elegans revealed that down-regulation of Hfq2 by h2cR decreases the B. cenocepacia ability to colonize and persist within the nematode, suggesting a role for h2cR on bacterial persistence in the host.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23082228 PMCID: PMC3474761 DOI: 10.1371/journal.pone.0047896
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Bacterial strains and plasmids used in this work.
| Strain | Description | Reference or source |
|
| CF sputum isolate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| This study |
|
|
| This study |
|
|
| This study |
|
|
| This study |
|
|
| This study |
|
|
| This study |
|
|
| This study |
|
|
| This study |
|
|
| This study |
|
| Host for recombinant protein expression | Stratagene |
|
| Host for recombinant plasmids | Invitrogen |
| Plasmids | ||
| pCR II | ApR; KmR; TOPO-TA cloning plasmid | Invitrogen |
| pET23a+ | ApR, used for C-terminal 6×histidine-tagged protein expression. | Stratagene |
| pMLBAD | TmpR; used for gene expression in Bcc |
|
| pBBR1MCS | CmR; used for gene expression in Bcc |
|
| pSAS5 | pWH884 with the |
|
| pSAS6 | pET23a+ with the | (Sousa, SA, Leitão JH) Unpublished data |
| pSAS3 (p | pMLBAD with the |
|
| pCGR4 | pET23a+ with the |
|
| pCGR10 | pCR II with the 136 bp cDNA fragment of the h2cR sRNA TA-cloned | This study |
| pCGR11 | pCR II with the 668 bp cDNA fragment of the | This study |
| pCGR12 | pCR II with the 216 bp cDNA fragment of the 5′UTR | This study |
| pCGR13 | pCR II with the 216 bp cDNA fragment of the5′UTR | This study |
| pCGR14 | pCR II with the 136 bp cDNA fragment of the h2cR RNA cloned in the HindIII/BamHI sites (T7 promoter control) | This study |
| pCGR17 (ph2cR) | pMLBAD with the 136 bp cDNA fragment of the h2cR RNA cloned in the XbaI/HindIII sites | This study |
| pCGR18 (h2cRsil) | pMLBAD with the 104 bp anti sense cDNA fragment of the h2cR with a cca extension cloned in the EcoRI/XbaI sites | This study |
| pCGR26 | pCGR13 with the his-tagged Hfq2 cloned in the HindIII/EcoRI sites | This study |
| pCGR27 (pThfq2) | pBBR1MCS with the N-terminus 6xhistidine tagged | This study |
| pCGR28 | pCR II with the 180 bp cDNA fragment of the −220 to −40 region of | This study |
| pCGR29 | pCR II with the 100 bp cDNA fragment of the −70 to +30 region of | This study |
| pCGR30 | pCR II with the250 bp cDNA fragment of the −220 to +30 region of | This study |
| pCGR31 | pBBR1 with the 136 bp cDNA fragment of the h2cR RNA cloned in the XbaI/HindIII sites | This study |
| pCGR32 | pBBR1 with the 104 bp anti sense cDNA fragment of the h2cR with a cca extension cloned in the EcoRI/XbaI sites | This study |
Oligonucleotides and primers used in this work.
| Name | Sequence (5′–3′) | Purpose | Reference or source |
| M13 Fwd M13 Rev | CTGGCCGTCGTTTTAC CAGGAAACAGCTATGAC | PCR screening of clones and transcription template Northern analysis of | Invitrogen Invitrogen |
| HFQ |
| ||
| HFQ2 |
|
| |
| 5S |
|
| |
| NBh2c |
| Northern blot analysis of h2cR | This study |
| T7-TSS-H2 |
| In vitro transcription of the of | This study |
| Hfq2c_Rev |
|
| |
| 5H2-H |
| In vitro transcription of the 5′UTR of | This study |
| 5H2-B |
| This study | |
| h2cR-H |
| In vitro transcription of the h2cR sRNA In vitro transcription of the h2cR sRNA | This study |
| h2cR-B |
| This study | |
| h2cR-X |
| Overexpression of h2cR | This study |
| h2cR-H2 |
| Overexpression of h2cR | This study |
| h2cR-E |
| Silencing of h2cR | This study |
| h2cR-Xcca |
| Silencing of h2cR | This study |
| CGRO100 |
| Amplification of the −220 region | This study |
| CGRO101 |
| Amplification of the −40 region | This study |
| CGRO103 |
| Amplification of the −70 region | This study |
| CGRO104 |
| Amplification of the +30 region | This study |
| 5′ RACE Adapter | 5′-GCUGAUGGCGAUGAAUGAACACUGC GUUUGCUGGCUUUGAUGAAA-3′ | 5′ RACE h2cR | Ambion |
| 5′ RACE Outer Primer |
| 5′ RACE h2cR | Ambion |
| 5′ RACE Inner Primer |
| 5′ RACE h2cR | Ambion |
| 5′R |
| 5′ RACE h2cR | This study |
Figure 1Genome location and transcriptional analysis of the h2cR sRNA in B. cenocepacia J2315.
(A) Genomic location of h2cR, showing in the upper part the 5′-UTR of thehfq2 gene, highlighting the direction of transcription of this gene (depicted by an open arrow and showing the ATG codon), the region where h2cR is inscribed (dark grey box), and the 5′-UTR region of hfq2 lacking h2cR complementarity (light grey box). A solid arrow in the lower part represents the h2cR transcript. The oligonucleotide used for 5′-RACE (5′R) experiments with h2cR is also shown. (B) h2cR RNA sequence and predicted secondary structure, showing the predicted folding energy. (C) Northern blot analysis of h2cR transcription in B. cenocepacia J2315 cells harvested from cultures grown for the indicated time. (D) Photograph of a 7.5% PAGE gel after electrophoresis of the PCR products obtained from 5′-RACE experiments of the h2cR sRNA, using the specific oligonucleotide 5′R, and 1 µg of total RNA obtained from B. cenocepacia J2315 cells in the exponential (2 h), late-exponential (8 h) of stationary (24 h) phases of growth.
Figure 2h2cR regulates hfq2 mRNA levels.
Northern blot analysis of the effects of h2cR overexpression (+ph2cR) or silencing (h2cRsil) on (A) hfq2 mRNA levels (left panel) and hfq2 mRNA stability (right panel) or (B) h2cR sRNA levels (left panel) and h2cR sRNA stability (right panel) in the wt, the Δhfq mutant, and derivative strains. h2cR silencing or overexpression was achieved by means of expressing from a pBAD inducible plasmid a 104 nt truncated form of an h2cR-complementary RNA with a CCA trinucleotide extension, or the h2cR sRNA, respectively. The hfq mutant strain (Δhfq) and derivative strains overexpressing hfq (Δhfq +phfq) or hfq2 (Δhfq+phfq2) from a pBAD inducible plasmid [45] were also used to access the possible roles of Hfq, or Hfq2 on hfq2 mRNA and h2cR expression and stability, respectively. RNA decay experiments were conducted using total RNA obtained from cells grown for 2-h (h2cR) or 24-h (hfq2 mRNA). After addition of rifampicin (time 0), samples were taken at the indicated time. Half-life times (t1/2) were calculated by least-square fitting to the linear part of the logarithm of the percentage of remaining RNA versus time. Values indicated are the means of three independent experiments.
Figure 3Analysis of the effect of h2cR overexpression or silencing on the Hfq2 protein and hfq2 mRNA.
Hfq2 levels were assessed by Western blotting (WB) while the hfq2 mRNA levels were assessed by Northern blotting (NB). Transcription and translation experiments were performed using total RNA obtained from cells grown for the indicated time. The relative intensity of bands was estimated considering as unitary the intensity of the bands for cells of the CJ6, CJ7 or CJ8 strains, grown for 2 h, and using as reference the intensity of the 5S rRNA bands. Western blot analysis was performed using 20 µg of total protein per lane, estimated in a Nanodrop ND1000 spectrophotometer. Results shown are representative of at least 4 independent experiments.
Figure 4h2cR interacts specifically with the 5′UTR of hfq2 mRNA.
(A) EMSA experiments using 2.5 nM of the h2cR together with the indicated amounts of the hfq2 full transcript or (B) the hfq2 coding sequence; (C) EMSA experiments using with 2.5 nM of h2cR, together with the indicated amounts of the hfq2 5′UTR derivatives full 5′-UTR (nt −220 to +30), the RNA segment spanning nt −220 to −40 of the 5′-UTR, or the RNA segment spanning nt −70 to +30 of the 5′-UTR. For the full 5′-UTR and the RNA segment spanning nt −70 to +30 of the 5′-UTR 0, 0.1, 0.5, 2.5 or 10 nM of the respective 5′-UTR RNA derivatives were used, while for the RNA segment spanning nt −220 to −40 of the 5′-UTR 0, 0.1, 0,5, or 2.5 nM of RNA were used. (D) Ability of Hfq to bind 2.5 nM of h2cR (left panel) or the hfq2 5′-UTR (right panel), as evaluated by EMSA assays using the indicated concentrations of the hexameric form of Hfq. Apparent Kd values were calculated based on a semi-log plot of the RNA binding ratio versus protein concentration, using a exponential fit.
Figure 5h2cR is required for B. cenocepacia J2315 virulence to C. elegans.
(A) Ability of the B. cenocepacia strains J2315 (wt), either with the h2cR silenced (h2cRsil) or overexpressed (ph2cR), and the respective control plasmid (pBBR1MCS) to kill C. elegans. (B) Number of colony forming units (CFU) of B. cenocepacia strains J2315 (wt), either with the h2cR silenced (h2cRsil) or overexpressed (ph2cR) and the respective control plasmid (pMLBAD) colonizing the nematodes' digestive tract. The asterisks represent P values of the WT values versus all the rest.
Figure 6The h2cR sRNA affects the levels of the Hfq2 protein and the hfq2 mRNA in B. cenocepacia cells infecting C. elegans.
Levels of the Hfq2 protein and of h2cR transcript and hfq2 mRNA in B. cenocepacia cells harvest from nematodes after the indicated post-infection time. Hfq2 protein levels were quantified by Western blot (WB), while h2cR and hfq2 mRNA levels were quantified by Northern blot analysis (NB). The relative intensity of bands (RI) was estimated considering as unitary the intensity of the bands for cells of the CJ6, CJ7 or CJ8 strains grown for 2 h, and using as reference the intensity of the 5S rRNA bands. Western blot analysis was performed using 1 µg of total protein per lane, estimated in a Nanodrop ND1000 spectrophotometer. Results shown are representative of at least 4 independent experiments. Error bars are the means standard deviation.